Current measurement apparatus, molecular entity sensing apparatus, method of measuring a current, method of sensing a molecular entity
US-2024426772-A1 · Dec 26, 2024 · US
US2024044865A1 · US · A1
| Field | Value |
|---|---|
| Publication number | US-2024044865-A1 |
| Application number | US-202318357504-A |
| Country | US |
| Kind code | A1 |
| Filing date | Jul 24, 2023 |
| Priority date | Dec 2, 2019 |
| Publication date | Feb 8, 2024 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Provided herein are methods of characterising a target polypeptide as it moves with respect to a nanopore. Also provided are related kits, systems and apparatuses for carrying out such methods.
Opening claim text (preview).
1 . A method of characterising a target polypeptide, comprising (i) conjugating the target polypeptide to a polynucleotide to form a polynucleotide-polypeptide conjugate; (ii) contacting the conjugate with a polynucleotide-handling protein; (ii) controlling the movement of the polynucleotide with respect to a transmembrane protein pore using the polynucleotide-handling protein; and (iv) taking one or more measurements characteristic of the polypeptide as the conjugate moves with respect to the transmembrane protein pore, thereby characterising the polypeptide; wherein the conjugate comprises a leader that facilitates the threading of the conjugate through the transmembrane protein pore. 2 - 8 . (canceled) 9 . The method according to claim 1 , wherein the polynucleotide-handling protein is a helicase. 10 . The method according to claim 1 , wherein the conjugate comprises a plurality of polypeptide sections and/or a plurality of polynucleotide sections. 11 . The method according to claim 1 , wherein the polypeptide has a length of from 2 to about 50 peptide units. 12 . (canceled) 13 . The method according to claim 1 , wherein the polynucleotide has a length of from about 10 to about 1000 nucleotides. 14 . The method according to claim 1 , wherein one or more adapters a are attached to the polynucleotide in the conjugate. 15 . The method according to claim 1 , wherein: (i) the polynucleotide-handling protein is located on the cis side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of the conjugate from the cis side of the transmembrane protein pore to the trans side of the transmembrane protein pore; or (ii) the polynucleotide-handling protein is located on the trans side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of the conjugate from the trans side of the transmembrane protein pore to the cis side of the transmembrane protein pore. 16 - 17 . (canceled) 18 . The method according to claim 1 , wherein the conjugate comprises one or more structures of the form L-{P-N}-P m , wherein: (a) L is a leader; (b) P is a polypeptide; (c) N comprises a polynucleotide; and (d) m is 0 or 1; and wherein the method comprises threading the leader (L) through the transmembrane protein pore thereby contacting the polypeptide (P) with the transmembrane protein pore; and (i) the polynucleotide-handling protein is located on the cis side of the transmembrane protein pore and the method comprises allowing the polynucleotide-handling protein to control the movement of the polynucleotide moiety (N) from the cis side of the transmembrane protein pore to the trans side of the transmembrane protein pore, thereby controlling the movement of the polypeptide (P) through the transmembrane protein pore; or (ii) the polynucleotide-handling protein is located on the trans side of the transmembrane protein pore and the method comprises allowing the polynucleotide-handling protein to control the movement of the polynucleotide moiety (N) from the trans side of the transmembrane protein pore to the cis side of the transmembrane protein pore, thereby controlling the movement of the polypeptide (P) through the transmembrane protein pore. 19 . The method according to claim 18 , wherein the conjugate comprises one or more structures of the form L-P 1 -N-{P-N} n -P m , wherein: (a) n is a positive integer; (b) L is a leader; (c) each P, which may be the same or different, is a polypeptide; (d) each N, which may be the same or different, comprises a polynucleotide; and (e) m is 0 or 1; and wherein the method comprises threading the leader (L) through the transmembrane protein pore thereby contacting polypeptide (P 1 ) with the transmembrane protein pore, and (i) the polynucleotide-handling protein is located on the cis side of the transmembrane protein pore and the method comprises allowing the polynucleotide-handling protein to control the movement of each polynucleotide (N) sequentially from the cis side of the transmembrane protein pore to the trans side of the transmembrane protein pore, thereby controlling the movement of each polypeptide (P) sequentially through the transmembrane protein pore; or (ii) the polynucleotide-handling protein is located on the trans side of the transmembrane protein pore and the method comprises allowing the polynucleotide-handling protein to control the movement of each polynucleotide (N) sequentially from the trans side of the transmembrane protein pore to the cis side of the transmembrane protein pore, thereby controlling the movement of each polypeptide (P) sequentially through the transmembrane protein pore 20 . The method according to claim 1 , wherein: (i) the polynucleotide-handling protein is located on the cis side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of the conjugate from the trans side of the transmembrane protein pore to the cis side of the transmembrane protein pore; or (ii) the polynucleotide-handling protein is located on the trans side of the transmembrane protein pore and the polynucleotide-handling protein controls the movement of the conjugate from the cis side of the transmembrane protein pore to the trans side of the transmembrane protein pore. 21 - 22 . (canceled) 23 . The method according to claim 1 , wherein the conjugate comprises one or more structures of the form L-{P-N}-P m , wherein: (a) L is a leader; (b) P is a polypeptide; (c) N comprises a polynucleotide; (d) m is 0 or 1; and wherein the method comprises threading the leader (L) through the transmembrane protein pore thereby contacting the polypeptide (P) with the transmembrane protein pore, and (i) the polynucleotide-handling protein is located on the cis side of the transmembrane protein pore and the method comprises allowing the polynucleotide-handling protein to control the movement of the polynucleotide (N) from the trans side of the transmembrane protein pore to the cis side of the transmembrane protein pore, thereby controlling the movement of the polypeptide (P) through the transmembrane protein pore; or (i) the polynucleotide-handling protein is located on the trans side of the transmembrane protein pore and the method comprises allowing the polynucleotide-handling protein to control the movement of the polynucleotide (N) from the cis side of the transmembrane protein pore to the trans side of the transmembrane protein pore, thereby controlling the movement of the polypeptide (P) through the transmembrane protein pore. 24 . (canceled) 25 . The method according to claim 1 , wherein the one or more measurements are characteristic of one or more characteristics of the polypeptide selected from (i) the length of the polypeptide, (ii) the identity of the polypeptide, (iii) the sequence of the polypeptide, (iv) the secondary structure of the polypeptide and (v) whether or not the polypeptide is modified. 26 - 31 . (canceled) 32 . The method according to claim 1 , wherein the leader comprises a polynucleotide or a charged polymer. 33 . The method according to claim 1 , wherein the conjugate comprises one or more structures of the form L-{P-N}-P m , wherein: (a) L is a leader; (b) P is a polypeptide; (c) N comprises a polynucleotide; and (d) m is 0 or 1; and wherein the method comprises threading the leader (L) through the transmembrane protein pore thereby contacting the polypeptide (P) with the tr
Labels used in chemical analysis of biological material · CPC title
Marker; Tag · CPC title
Investigating individual macromolecules, e.g. by translocation through nanopores (Coulter counters in general G01N15/12; fabrication methods for nanoscale apertures B81B1/00; sequencing of nucleic acids C12Q1/68) · CPC title
Sequencing of polypeptides · CPC title
DNA or RNA fragments; Modified forms thereof (DNA or RNA not used in recombinant technology, C07H21/00); {Non-coding nucleic acids having a biological activity} · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.